This is the first study relating LA volumes and function assessed by 2DSTE to MS. 2D speckle tracking analysis of LA volume is relatively easy and provides more detailed information regarding the changes in LA volumes during the cardiac cycle.
Although the origin of cardiac syndrome X (CSX) is still debated, endothelial dysfunction leading to reduced coronary microvascular dilatory response and increased coronary resistance is thought to have an important role in the pathogenesis. Erectile dysfunction (ED) is associated with risk factors resulting in endotelial dysfunction. Although the relationship between cardiovascular disease and ED has been well established; the relation between CSX and ED has not been extensively studied so far. We herein aimed to study ED in patients with CSX. The study was designed as a prospective case-control study. Blood samples were analyzed with respect to concentrations of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides. The subjects answered the native language five-item version of the International Index of Erectile Function Questionnaire (IIEF)-5. Each question was scored from 0 to 5 with a maximum score of 25 denoting healty subjects. We investigated the IIEF-5 score in 51 men with CSX (mean age=48.2±6.4 years), 53 men with demonstrated coronary artery disease (CAD) (mean age=48.3±4.8 years) and 52 male controls with normal coronary arteries (mean age=47.2±6.0 years). Mean IIEF-5 scores were 19.88±3.07 for CSX group, 18.83±3.31 for CAD group and 21.40±2.94 for control group. IIEF-5 scores in CSX group were found to be significantly lower than the those of control group (P<0.001). There were no significant differences in IIEF-5 scores between CSX and CAD groups (P=0.09). We have shown for the first time that patients with CSX have lower IIEF-5 scores compared with controls with normal coronary angiograms. This study suggests that ED and CSX may be different manifestations of a common underlying vascular pathology and vasculogenic ED is frequently seen in CSX at least as much as in CAD.
Background:Epicardial fat is an upper body visceral fat depot that may play a
significant role in the development of adverse metabolic and cardiovascular
risk profiles. There is a significant direct relationship between the amount
of epicardial fat and general body adiposity (body mass index, BMI), but
data regarding subcutaneous adiposity is limited.Objective:We conducted a study to determine the association between neck circumference
and epicardial fat thickness in healthy young male individuals, and assess
their individual correlations with general body adiposity and
cardiometabolic risk factors.Methods:One hundred consecutive male patients aged 18 years or older with no known
major medical conditions were included in the study. All participants
underwent detailed physical examination including measurement of blood
pressure, weight, height, waist/hip ratio, and neck circumference. Blood was
collected to determine fasting glucose and lipid parameters. A standard
echocardiographic examination was performed with additional epicardial fat
thickness determination.Results:Among 100 study participants, neck circumference correlated significantly
with weight, waist circumference, BMI, blood glucose, serum total
cholesterol, low-density (LDL)-cholesterol, and triglycerides levels. No
significant correlation was found between neck circumference and
high-density lipoprotein (HDL)-cholesterol levels. Neck circumference
correlated moderately and positively with echocardiographic epicardial fat
thickness.Conclusion:Among patients with low cardiometabolic risk, increased neck circumference
was associated with increased epicardial fat thickness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.